Authors

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Current Management of Glaucoma and the Need for Complete Therapy

At Hearing on Recurring Cancer Drug Shortages, Rural Areas Come Into Focus

Implementation of Cancer Clinical Care Pathways

Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients

This study evaluated economic outcomes of an insurer-led care management program for high-cost Medicaid patients using teams of community health care workers and nurses.

Successful Implementation of APSO Notes Across a Major Health System

In this study, the authors demonstrate widespread adoption and satisfaction with the novel APSO (Assessment, Plan, Subjective, Objective) format for progress notes at a large, integrated health delivery network.

An Overview of Viral Hepatitis

Two-Sided Risk in the Oncology Care Model

The US healthcare system remains one of the most inefficient healthcare systems in the world. The Bloomberg Health-Care Efficiency Index ranked the United States 54th among 56 countries in 2018, tied with Azerbaijan and only ahead of Bulgaria. This occurs even though the United States spends $10,244 per capita annually on healthcare, a figure representing 17% of the gross domestic product.

Racial and Ethnic Disparity in Palliative Care and Hospice Use

Race/ethnicity was not a predictor of inpatient palliative care consultation or discharge to hospice in 4 hospitals with an inpatient palliative care service.

Impact of COVID-19 on Specialty Televisits in a Large Integrated Health Care System

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.

Partnerships Power Access to Advanced Oncology Therapies

Experts discussed value-based oncology care, CAR T-cell therapy access gaps, myeloma advances, and bispecific therapy challenges.

Is the Healthcare Workforce a Barrier to Cost Containment?

Education of Patients and Family: A JCAHO Requirement -- One Medical Center's Approach

Safety Net Representation in Federal Payment and Care Delivery Reform Initiatives

Although safety net organizations are eligible for some two-thirds of federal payment reform programs, fewer than 20% of these programs directly target the safety net.

Asthma Expenditures in the United States Comparing 2004 to 2006 and 1996 to 1998

Increased expenditures in US asthma are driven by increased medication spending that are not offset by decreases in emergency department and hospital spending.

Rates of Guideline Adherence Among US Community Oncologists Treating NSCLC

US community oncologists treating NSCLC were significantly more likely to be guideline adherent when providing first-line rather than adjuvant treatment.

Use of Alternative Pharmacotherapy in Management of Cardiovascular Diseases

Cost-Effectiveness of 70-Gene MammaPrint Signature in Node-Negative Breast Cancer

Targeting chemotherapy with 70-gene MammaPrint signature in patients 60 years or younger with node-negative breast cancer is likely to be cost-effective.

Overcoming Barriers to a Research-Ready National Commercial Claims Database

Lessons learned about data governance and distribution from a voluntary healthcare claims repository, the Health Care Cost Institute, a nonprofit research organization

Health Information Technology and the Medical School Curriculum

There are opportunities for and obstacles to adding core biomedical informatics competencies to medical school curricula.

Drivers of Expenditure Growth in Outpatient Care Services

Healthcare Utilization Associated with Dyspepsia in Patients with Arthritis

Cost-Sharing and Initiation of Disease-Modifying Therapy for Multiple Sclerosis

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.

Effects of a Medicaid Prior Authorization Policy for Pregabalin

State Medicaid programs’ pregabalin prior authorization accomplished the objective of lower pregabalin utilization; the unintended effects were increased opioid use and increased disease-related healthcare costs.

Introduction: Clinical Benefits of Combination Therapy in Managing Hypertension: A Paradigm for Managed Care

Prescribing Trend of Pioglitazone After Safety Warning Release in Korea

The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone users.

Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Adults

Implementation of Evidence-based Alcohol Screening in the Veterans Health Administration